Tabo-tabo, Petra A.

HRN: 25-11-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFTRIAXONE 1G (VIAL)
06/22/2026
06/29/2026
IVTT
2g
Q24H
CAP
Checking Initial Appropriateness 
06/22/2026
COTRIMOXAZOLE 960MG (TAB)
06/22/2026
06/28/2026
PO
960mg Tab
MWF
CML; Prophylaxis
Checking Initial Appropriateness 
06/30/2026
COTRIMOXAZOLE 960MG (TAB)
06/30/2026
07/06/2026
PO
960
Od
CML; Prophylaxis
Checking Initial Appropriateness 
07/09/2026
LEVOFLOXACIN 500MG (TAB)
07/09/2026
07/15/2026
ORAL
500mg
OD
Acute Lymphocytic Leukemia
Checking Initial Appropriateness 
07/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/19/2026
07/26/2026
IVTT
4.5g
Q6H
Febrile Neutropenia
Checking Final Appropriateness 
07/27/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/27/2026
08/02/2026
IV
650mg X 30 Mins
OD
Acute Cystitis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: